IBSA Pharma recalls TIROS: levothyroxine oral solution with subpotent drug risk. This medication may not provide proper thyroid hormone levels. Affected units have NDC 71858-0150-5 and lot #220959.
Subpotent Drug
IBSA Pharma is recalling a specific levothyroxine oral solution product because it may not contain enough active ingredient. This could lead to improper thyroid hormone levels in users who rely on this medication.
The product contains a subpotent drug, meaning it may not deliver the intended amount of levothyroxine. This could result in insufficient thyroid hormone levels for users who depend on this medication.
People prescribed this levothyroxine solution by a doctor are affected. Those with thyroid conditions requiring precise hormone levels are most at risk.
Check for the product name 'TIROSINT - SOL' with 150 microgram/mL concentration. The NDC code is 71858-0150-5 and lot number 220959.
Verify the product name, concentration, NDC code, and lot number to confirm if it matches the recalled item.
The recall indicates a potential risk of subpotent drug, but the product is not unsafe to use. Users should check if they have the specific recalled product.
The recall does not specify a remedy, so check the product details and contact your doctor if you are unsure.
Look for the product name 'TIROSINT - SOL', 150 microgram/mL concentration, NDC 71858-0150-5, and lot number 220959.
We’ve drafted a message you can send IBSA Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0344-2023 — IBSA Pharma IBSA Pharma Hello, I own a IBSA Pharma that is covered by recall D-0344-2023 from IBSA Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
